tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Dr. Reddy’s Laboratories Appoints New Secretarial Auditors

Story Highlights
Dr. Reddy’s Laboratories Appoints New Secretarial Auditors

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Dr Reddy’s Laboratories ( (RDY) ) has shared an update.

On July 24, 2025, Dr. Reddy’s Laboratories announced that its shareholders approved the appointment of Makarand M. Joshi & Co. as the Secretarial Auditors for a five-year term starting April 1, 2025. This decision, made during the company’s 41st Annual General Meeting, underscores Dr. Reddy’s commitment to maintaining robust corporate governance practices, potentially enhancing its credibility and operational transparency in the pharmaceutical industry.

The most recent analyst rating on (RDY) stock is a Buy with a $17.40 price target. To see the full list of analyst forecasts on Dr Reddy’s Laboratories stock, see the RDY Stock Forecast page.

Spark’s Take on RDY Stock

According to Spark, TipRanks’ AI Analyst, RDY is a Neutral.

The overall stock score of 68 reflects strong financial performance and reasonable valuation, offset by bearish technical indicators. The company’s solid balance sheet and consistent revenue growth bolster its financial health, but short-term market momentum suggests caution.

To see Spark’s full report on RDY stock, click here.

More about Dr Reddy’s Laboratories

Dr. Reddy’s Laboratories is a prominent pharmaceutical company based in Hyderabad, India. The company is known for its production of generic medications, active pharmaceutical ingredients, and biosimilars, with a focus on providing affordable healthcare solutions globally.

Average Trading Volume: 1,584,757

Technical Sentiment Signal: Strong Buy

Current Market Cap: $12.05B

For detailed information about RDY stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1